Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Coronavirus spreads from China to US

A new virus that presents with SARS-like symptoms has been discovered in China and already spread to at least two people in the United States, according to the CDC.

Thumbnail

Pharma industry lobbying hit $29M in 2019

The pharmaceutical industry upped its lobbying efforts in 2019, with a record-high of $29 million spent lobbying Congress.

Thumbnail

Civica Rx, Blue Cross Blue Shield tackle high-cost generic medications with new subsidiary

Civica Rx and the Blue Cross Blue Shield Association and 18 of its health plans have teamed up to create a new subsidiary that will target low-cost generic drugs.

Thumbnail

How US could fall behind China in AI development

The United States is still viewed as the world’s leader in researching and developing AI solutions—but could that reputation be at stake?

Thumbnail

$13.3B of healthcare administration could be automated

One-third of healthcare administrative spending could be automated and save $13.3 billion, according to a report by CAQH.

Thumbnail

Centene, WellCare $17.3B merger clears regulatory requirements

Centene has passed all regulatory hurdles to seal the deal on a merger with WellCare Health Plans worth $17.3 billion.

Thumbnail

Partnership aims to bring AI imaging solutions to Africa

Oxipit, a Lithuania-based medical imaging solutions manufacturer, and Healthcare Konnect, a Swiss distribution company, have announced a new partnership focused on delivering AI imaging solutions to Nigeria.

Thumbnail

Amazon ramps up trademarks for pharmacy business

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

Displaying 2105 - 2112 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup